Cheng Liu's most recent trade in Estrella Biopharma Inc was a trade of 100,000 Common Stock, par value $0.0001 per share done at an average price of $0.8 . Disclosure was reported to the exchange on Aug. 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Estrella Biopharma Inc | Cheng Liu | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.82 per share. | 25 Aug 2026 | 100,000 | 397,437 | - | 0.8 | 81,500 | Common Stock, par value $0.0001 per share |
| Estrella Biopharma Inc | Cheng Liu | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2026 | 100,000 | 900,000 | - | - | Incentive Stock Option | |
| Estrella Biopharma Inc | Cheng Liu | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2024 | 509,204 | 509,203 | - | - | Nonstatutory Share Option | |
| Estrella Biopharma Inc | Cheng Liu | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2024 | 490,796 | 490,796 | - | - | Incentive Share Option |